Singapore, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company") today closed its registered direct offering of 6,000,000 units, raising gross proceeds of US$7.98 million and
Singapore, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company") today entered into a placement agency agreement with Cathay Securities, Inc., as the placement agent (the
Singapore, July 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company") today announced that it has received notification from Nasdaq that the Company has regained compliance with
SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), a medical clinic operator in Singapore, today announced that the Company's board of directors has approved the
LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Basel Medical Group Ltd ("Basel"
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Basel Medical Group Ltd. (NASDAQ:BMGL) resulting from allegations that Basel
Singapore, March 24, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company") today announced that it has received notification from Nasdaq that based on the Company's amended annual report on
Singapore, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), today announced that it has received notification from Nasdaq that based on the closing bid price of the Company's
Singapore, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), today announced that it has received notification from Nasdaq that the Company's annual report on Form 20-F for the
Singapore, July 17, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL), today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough discussions, Basel and the
Singapore, June 26, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), today announced that Cathay Securities, Inc., as the representative of the several underwriters of the Company's
Singapore, May 29, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL), today reaffirmed the strength of its underlying financial performance and strategic outlook, despite recent volatility in its share
Singapore, May 22, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL), today announced that it has entered into a purchase agreement with a consortium of Bitcoin (BTC) holders for the purchase by the
Singapore, May 20, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL), today announced that its subsidiary has been awarded a significant contract worth S$375 million by Pancare Technology International
Singapore, May 16, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL), today announced that it has begun exclusive negotiations for a US$1 billion BTC acquisition that will diversify its treasury reserves